Seryl-tRNA Synthetase (SARS) (AA 2-233) 抗体 (FITC)
Quick Overview for Seryl-tRNA Synthetase (SARS) (AA 2-233) 抗体 (FITC) (ABIN1046073)
抗原
See all Seryl-tRNA Synthetase (SARS) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 2-233
-
交叉反应
- 人
-
纯化方法
- >95%, Protein G purified
-
免疫原
- Recombinant Human Serine--tRNA ligase, cytoplasmic protein (2-233AA)
-
亚型
- IgG
-
-
anti-Seryl-tRNA Synthetase (SARS) (AA 1-514) antibody
SARS 适用: 人 WB, ELISA, IF, IHC (p), RNAi 宿主: 小鼠 Monoclonal 1H4 unconjugated
anti-Seryl-tRNA Synthetase (SARS) (AA 1-300) antibodySARS 适用: 人 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Seryl-tRNA Synthetase (SARS) (AA 2-233) antibodySARS 适用: 人 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Seryl-tRNA Synthetase (SARS) (AA 1-300) antibodySARS 适用: 人 WB, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Seryl-tRNA Synthetase (SARS) antibodySARS 适用: 人, 小鼠, 大鼠 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Seryl-tRNA Synthetase (SARS) antibodySARS 适用: 人, 小鼠, 大鼠 WB, IHC, IF, IC 宿主: 兔 Polyclonal unconjugated
anti-Seryl-tRNA Synthetase (SARS) (AA 1-514) antibodySARS 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Seryl-tRNA Synthetase (SARS) (C-Term) antibodySARS 适用: 人, 小鼠, 大鼠, 犬 WB 宿主: 兔 Polyclonal unconjugated
anti-Seryl-tRNA Synthetase (SARS) (AA 394-422), (C-Term) antibodySARS 适用: 人 WB, IHC (p) 宿主: 兔 Polyclonal RB14980 unconjugated
-
-
应用备注
- Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
注意事项
- Avoid freeze and thaw cycles. Product is photosensitive and should be protected from light.
-
储存条件
- -20 °C,-80 °C
-
储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Seryl-tRNA Synthetase (SARS)
-
别名
- SARS
-
背景
-
Background: Catalyzes the attachment of serine to tRNA(Ser) in a two-step reaction: serine is first activated by ATP to form Ser-AMP and then transferred to the acceptor end of tRNA(Ser) (PubMed:22353712, PubMed:24095058, PubMed:9431993, PubMed:26433229, PubMed:28236339). Is probably also able to aminoacylate tRNA(Sec) with serine, to form the misacylated tRNA L-seryl-tRNA(Sec), which will be further converted into selenocysteinyl-tRNA(Sec) (PubMed:9431993, PubMed:26433229, PubMed:28236339). In the nucleus, binds to the VEGFA core promoter and prevents MYC binding and transcriptional activation by MYC (PubMed:24940000). Recruits SIRT2 to the VEGFA promoter, promoting deacetylation of histone H4 at \\\'Lys-16\\\' (H4K16). Thereby, inhibits the production of VEGFA and sprouting angiogenesis mediated by VEGFA (PubMed:19423848, PubMed:19423847, PubMed:24940000).
Aliases: C78314 antibody, cytoplasmic antibody, EC 6.1.1.11 antibody, FLJ36399 antibody, sarS antibody, Sars1 antibody, Serine tRNA ligase 1, cytoplasmic antibody, Serine tRNA ligase antibody, Serine--tRNA ligase antibody, serine--tRNA ligase, cytoplasmic antibody, SerRS antibody, SERS antibody, Seryl tRNA Ser/Sec synthetase antibody, Seryl tRNA synthetase antibody, Seryl tRNA synthetase cytoplasmic antibody, Seryl-tRNA Ser/Sec synthetase antibody, Seryl-tRNA synthetase antibody, seryl-tRNA synthetase, cytoplasmic antibody, Seryl-tRNA(Ser/Sec) synthetase antibody, Strs antibody, SYSC_HUMAN antibody
-
UniProt
- P49591
抗原
-
